Quipt Home Medical Corp.

TSX:QIPT Stock Report

Market Cap: CA$153.8m

Quipt Home Medical Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Greg Crawford

Chief executive officer

US$1.9m

Total compensation

CEO salary percentage31.8%
CEO tenure7yrs
CEO ownership6.9%
Management average tenure6.8yrs
Board average tenure7yrs

Recent management updates

Recent updates

We Like These Underlying Return On Capital Trends At Quipt Home Medical (TSE:QIPT)

Dec 15
We Like These Underlying Return On Capital Trends At Quipt Home Medical (TSE:QIPT)

Earnings Release: Here's Why Analysts Cut Their Quipt Home Medical Corp. (TSE:QIPT) Price Target To CA$10.95

Aug 17
Earnings Release: Here's Why Analysts Cut Their Quipt Home Medical Corp. (TSE:QIPT) Price Target To CA$10.95

Is Quipt Home Medical (TSE:QIPT) A Risky Investment?

Aug 16
Is Quipt Home Medical (TSE:QIPT) A Risky Investment?

Quipt Home Medical Corp.'s (TSE:QIPT) 26% Price Boost Is Out Of Tune With Revenues

Jul 26
Quipt Home Medical Corp.'s (TSE:QIPT) 26% Price Boost Is Out Of Tune With Revenues

Returns At Quipt Home Medical (TSE:QIPT) Are On The Way Up

Jul 17
Returns At Quipt Home Medical (TSE:QIPT) Are On The Way Up

Investors Aren't Entirely Convinced By Quipt Home Medical Corp.'s (TSE:QIPT) Revenues

Apr 19
Investors Aren't Entirely Convinced By Quipt Home Medical Corp.'s (TSE:QIPT) Revenues

Quipt Home Medical Corp. (TSE:QIPT) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates

Feb 17
Quipt Home Medical Corp. (TSE:QIPT) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates

What Is Quipt Home Medical Corp.'s (TSE:QIPT) Share Price Doing?

Sep 25
What Is Quipt Home Medical Corp.'s (TSE:QIPT) Share Price Doing?

Calculating The Fair Value Of Quipt Home Medical Corp. (TSE:QIPT)

Sep 01
Calculating The Fair Value Of Quipt Home Medical Corp. (TSE:QIPT)

We Think Quipt Home Medical's (CVE:QIPT) Robust Earnings Are Conservative

Feb 21
We Think Quipt Home Medical's (CVE:QIPT) Robust Earnings Are Conservative

Earnings Update: Quipt Home Medical Corp. (CVE:QIPT) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts

Aug 18
Earnings Update: Quipt Home Medical Corp. (CVE:QIPT) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts

Health Check: How Prudently Does Quipt Home Medical (CVE:QIPT) Use Debt?

Jul 13
Health Check: How Prudently Does Quipt Home Medical (CVE:QIPT) Use Debt?

When Should You Buy Quipt Home Medical Corp. (CVE:QIPT)?

Jun 08
When Should You Buy Quipt Home Medical Corp. (CVE:QIPT)?

Quipt Home Medical Corp. (CVE:QIPT) Shares Could Be 43% Below Their Intrinsic Value Estimate

Jun 02
Quipt Home Medical Corp. (CVE:QIPT) Shares Could Be 43% Below Their Intrinsic Value Estimate

Does Protech Home Medical (CVE:PTQ) Have A Healthy Balance Sheet?

May 07
Does Protech Home Medical (CVE:PTQ) Have A Healthy Balance Sheet?

Protech Home Medical Corp. (CVE:PTQ) Could Be Less Than A Year Away From Profitability

Mar 29
Protech Home Medical Corp. (CVE:PTQ) Could Be Less Than A Year Away From Profitability

Can You Imagine How Elated Protech Home Medical's (CVE:PTQ) Shareholders Feel About Its 331% Share Price Gain?

Feb 22
Can You Imagine How Elated Protech Home Medical's (CVE:PTQ) Shareholders Feel About Its 331% Share Price Gain?

Calculating The Fair Value Of Protech Home Medical Corp. (CVE:PTQ)

Jan 18
Calculating The Fair Value Of Protech Home Medical Corp. (CVE:PTQ)

CEO Compensation Analysis

How has Greg Crawford's remuneration changed compared to Quipt Home Medical's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$7m

Jun 30 2024n/an/a

-US$5m

Mar 31 2024n/an/a

-US$4m

Dec 31 2023n/an/a

-US$4m

Sep 30 2023US$2mUS$597k

-US$3m

Jun 30 2023n/an/a

US$310k

Mar 31 2023n/an/a

US$2m

Dec 31 2022n/an/a

US$7m

Sep 30 2022US$843kUS$558k

US$5m

Jun 30 2022n/an/a

US$2m

Mar 31 2022n/an/a

US$8m

Dec 31 2021n/an/a

-US$10m

Sep 30 2021US$4mUS$513k

-US$6m

Jun 30 2021n/an/a

-US$5m

Mar 31 2021n/an/a

-US$14m

Dec 31 2020n/an/a

US$1m

Sep 30 2020US$440kUS$425k

-US$4m

Jun 30 2020n/an/a

US$428k

Mar 31 2020n/an/a

-US$6m

Dec 31 2019n/an/a

-US$11m

Sep 30 2019US$652kUS$425k

-US$7m

Jun 30 2019n/an/a

-US$27m

Mar 31 2019n/an/a

-US$18m

Dec 31 2018n/an/a

-US$20m

Sep 30 2018US$1mUS$418k

-US$7m

Compensation vs Market: Greg's total compensation ($USD1.88M) is above average for companies of similar size in the Canadian market ($USD164.07K).

Compensation vs Earnings: Greg's compensation has increased whilst the company is unprofitable.

CEO

Greg Crawford

7yrs

Tenure

US$1,878,047

Compensation

Mr. Gregory J. Crawford also known as Greg, serves as Director at DMEscripts LLC. He has been President, Chief Executive Officer and Chairman of Quipt Home Medical Corp. (formerly known as Protech Home Med...

Leadership Team

NamePositionTenureCompensationOwnership
Gregory Crawford
Chairman7yrsUS$1.88m6.85%
CA$ 10.5m
Hardik Mehta
Chief Financial Officer6.8yrsUS$1.71m1.84%
CA$ 2.8m
David Bachelder
Executive Vice President of Operations3.2yrsno data0.0050%
CA$ 7.7k
William Zehnder
Chief Strategy Officer & Investor Relationsno dataUS$308.24kno data
Cole Stevens
VP of Corporate Development & VP of Investor Relationsno datano datano data
Mark Miles
Vice President of Information Technologyno datano datano data
Thomas Roehrig
Executive Vice President of Finance5.3yrsno data0.055%
CA$ 84.3k
Patrick Gamble
Executive Vice President of Operationsno datano data0.054%
CA$ 82.3k
Robert Grossman
Corporate Secretary12.9yrsno datano data

6.8yrs

Average Tenure

50yo

Average Age

Experienced Management: QIPT's management team is seasoned and experienced (6.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Gregory Crawford
Chairman7yrsUS$1.88m6.85%
CA$ 10.5m
Mark Greenberg
Independent Non Executive Director7yrsUS$1.10m0.47%
CA$ 718.2k
Steven Axelrod
Member of the Board of Advisors11.2yrsno datano data
Jim Booth
Member of the Board of Advisors11.2yrsno datano data
Kevin Carter
Independent Non-Executive Director4yrsUS$476.95k0.12%
CA$ 178.5k
Brian Wessel
Independent Director2.8yrsUS$660.88k0.098%
CA$ 151.3k

7.0yrs

Average Tenure

Experienced Board: QIPT's board of directors are considered experienced (7 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 02:08
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2024/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Quipt Home Medical Corp. is covered by 11 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ishan MajumdarBaptista Research
Doug CooperBeacon Securities Limited
William SutherlandBenchmark Company